Dengue in Nicaragua, 1994: Reintroduction of serotype 3 in the Americas;Dengue en Nicaragua, 1994: Reintroduccion del serotipo 3 en las Americas

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 1, Issue 3, 1997, Pages 193-199

  Guzmán, María G ^a   Vázquez, Susana ^a   Martínez, Eric ^b   Álvarez, Mayling ^a   Rodríguez, Rosmary ^a   Kourí, Gustavo ^a   De Los Reyes, José ^c   Acevedo, Francisco ^c  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b Juan Manuel Marquez Pediatric Hospital   (Cuba)

^c Ministry of Health   (Nicaragua)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CLINICAL FEATURE; DENGUE; DISEASE CARRIER; EPISTAXIS; FEVER; HEADACHE; HUMAN; MYALGIA; VOMITING;

EID: 0343990083     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49891997000300005     Document Type: Article

References (27)

1. Organización Panamericana de la Salud, Programa de Enfermedades Transmisibles. El dengue y la fiebre hemorrágica del dengue en las Américas: una vision general del problema. Bol Epidemiol 1992;13:9-10.
2. Pan American Health Organization. Dengue in the Caribbean, 1977. Washington, DC: PAHO; 1979. (Scientific publication 375).
3. Kourí G, Guzmán MG, Bravo J. Hemorrhagic dengue in Cuba: history of an epidemic. Bull Pan Am Health Organ 1986;20:24-30.
4. Organización Panamericana de la Salud, Programa de Enfermedades Transmisibles, División de Prevención y Control de Enfermedades Transmisibles. Dengue en Costa Rica y Panamá. Bol Epidemiol 1994;15:9-10.
5. Organización Panamericana de la Salud, Programa de Enfermedades Transmisibles, División de Prevención y Control de Enfermedades Transmisibles. Dengue en las Américas: una actualización. Bol Epidemiol 1993; 14:1-3.
6. Kourí G, Valdez M, Argüello L, Guzmán MG, Valdez L, Soler M, et al. Epidemia de dengue en Nicaragua, 1985. Rev Inst Med Trop (São Paulo) 1991;33:365-371.
7. República de Nicaragua, Ministerio de Salud. Informe sobre la situación del dengue y las acciones de control. Managua: Ministerio de Salud; 1994.
8. Kuno G, Gómez I, Gubler D. An ELISA procedure for the diagnosis of dengue infections. J Virol Methods 1991;33:101-113.
9. Clarke DH, Casals J. Techniques for hemagglutination and hemagglutination inhibition with arthropod borne viruses. Am J Trop Med Hyg 1958;7:561-573.
10. Fernández RJ, Vázquez S. Serological diagnosis of dengue by an ELISA inhibition method (EIM). Mem Inst Oswaldo Cruz (Rio de Janeiro) 1990;85:347-351.
11. Pan American Health Organization. Dengue and dengue hemorrhagic fever in the Americas: guidelines for prevention and control. Washington, DC: PAHO; 1994. (Scientific publication 548).
12. World Health Organization, Technical Advisory Committee on Dengue Haemorrhagic Fever for the South East Asian and Western Pacific Regions. Guide for diagnosis, treatment and control of dengue haemorrhagic fever. Geneva: WHO; 1980:7.
13. Ehrenkranz NJ, Ventura AK, Cuadrado RR, Pond WL, Porter JE. Pandemic dengue in Caribbean countries and the southern United States: past, present and potential problems. N Engl J Med 1971;85:1460-1469.
14. Morens DM, Rigau-Pérez JG, López-Correa RH, Moore CG, Ruiz-Tibén EE, Sather GE, et al. Dengue in Puerto Rico, 1977: public health response to characterize and control an epidemic of multiple serotypes. Am J Trop Med Hyg 1986;5:197-211.
15. United States, Centers for Disease Control and Prevention. Dengue type 3 infection: Nicaragua and Panama; October, November 1994. MMWR 1995;44:21-24.
16. th century dengue pandemic: need for surveillance and research. Rapp Trimest Stat Sanit Mond 1992;45:292-298.
17. Guzmán MG, Kourí G, Morier L, Soler M, Fernández A. A study of fatal hemorrhagic dengue cases in Cuba, 1981. Bull Pan Am Health Organ 1984;18:213-220.
18. Guzmán MG, Kourí G, Martínez E, Bravo J, Riverón R, Soler M, et al. Clinical and serologic study of Cuban children with dengue hemorrhagic fever, dengue shock syndrome (DHF/DSS). Bull Pan Am Health Organ 1987;2: 270-279.
19. Bravo J, Guzmán MG, Kourí G. Why dengue haemorrhagic fever in Cuba? I: individual risk factors for dengue haemorrhagic fever/ dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg 1987;81:816-820.
20. Nisalak A. Dengue virus isolations from Bangkok, Thailand, 1962-88. Virus Info Exch Newsl 1989;6:117.
21. Vitarana T. Dengue hemorrhagic fever. Ceylon Med J 1990;35:83-87.
22. Lanciotti RS, Lewis JG, Gubler D, Trent D. Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol 1994;75:65-75.
23. Chungue E, Deubel V, Cassar O, Laille M, Martin PM. Molecular epidemiology of dengue 3 viruses and genetic relatedness among dengue 3 strains isolated from patients with mild or severe form of dengue fever in French Polynesia. J Gen Virol 1993;74: 2765-2770.
24. Guzmán MG, Rosario D, Muné M, Álvarez M, Rodriguez R. Relaciones genéticas de los virus de dengue 3 aislados durante la epidemia de FHD de Nicaragua, 1994. Rev Cub Med Trop 1996;48:1.
25. Halstead SB. Dengue viruses in infectious diseases. In: Gorbach SL, Bartlett JG, Blacklow NR. Infectious diseases. Philadelphia: Saunders; 1992:1830-1835.
26. Kourí G, Guzmán MG, Bravo J. Why dengue haemorrhagic fever in Cuba? II: an integral analysis. Trans R Soc Trop Med Hyg 1987;81: 821-823.
27. Murphy FA, Nathanson N. The emergence of new virus diseases: an overview. Sem Virol 1994;5:87-102.